Pressurised metered dose inhalers (pMDI) are ubiquitous and are here to stay. We have applied 21st Century engineering techniques to bring the humble press-and-breathe device up to date with a high-clarity, front-mounted, low-cost 200 dose-by-dose counter, and a contemporary design. We are also developing a nasal variant.



Our breath-actuated inhaler (BAI) builds on the features of the press-and-breathe device, but is easier to use; patients simply Open-Inhale-Close.

We have complete control over critical device parameters, including resistance and trigger-flow-rate, enabling us to tune the device to specific therapeutic needs.




Our pre-metered dry powder inhaler (DPI) platform can accommodate multiple formulations, separately or in combination. It has an Open-Inhale-close user-interface and a high-clarity dose-counter.

It has been designed as a delivery device for generic Ellipta® products.